BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30814360)

  • 21. Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.
    Karl T; Bhatia S; Cheng D; Kim WS; Garner B
    Behav Brain Res; 2012 Mar; 228(2):392-7. PubMed ID: 22197298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease.
    Beauquis J; Vinuesa A; Pomilio C; Pavía P; Galván V; Saravia F
    Hippocampus; 2014 Mar; 24(3):257-69. PubMed ID: 24132937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer's Disease.
    Dhungana A; Becchi S; Leake J; Morris G; Avgan N; Balleine BW; Vissel B; Bradfield LA
    eNeuro; 2023 Feb; 10(2):. PubMed ID: 36650070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodic dietary restriction ameliorates amyloid pathology and cognitive impairment in PDAPP-J20 mice: Potential implication of glial autophagy.
    Gregosa A; Vinuesa Á; Todero MF; Pomilio C; Rossi SP; Bentivegna M; Presa J; Wenker S; Saravia F; Beauquis J
    Neurobiol Dis; 2019 Dec; 132():104542. PubMed ID: 31351172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
    Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
    Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain.
    Heiland T; Zeitschel U; Puchades MA; Kuhn PH; Lichtenthaler SF; Bjaalie JG; Hartlage-Rübsamen M; Roßner S; Höfling C
    Glia; 2019 Feb; 67(2):393-403. PubMed ID: 30485540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency in EP4 Receptor-Associated Protein Ameliorates Abnormal Anxiety-Like Behavior and Brain Inflammation in a Mouse Model of Alzheimer Disease.
    Fujikawa R; Higuchi S; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Hayashi K; Yokode M; Minami M
    Am J Pathol; 2017 Aug; 187(8):1848-1854. PubMed ID: 28624505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
    Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
    Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
    Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
    Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease.
    Kanamaru T; Kamimura N; Yokota T; Iuchi K; Nishimaki K; Takami S; Akashiba H; Shitaka Y; Katsura K; Kimura K; Ohta S
    Neurosci Lett; 2015 Feb; 587():126-31. PubMed ID: 25529196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
    Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
    Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein.
    Harris JA; Devidze N; Halabisky B; Lo I; Thwin MT; Yu GQ; Bredesen DE; Masliah E; Mucke L
    J Neurosci; 2010 Jan; 30(1):372-81. PubMed ID: 20053918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease.
    Beauquis J; Pavía P; Pomilio C; Vinuesa A; Podlutskaya N; Galvan V; Saravia F
    Exp Neurol; 2013 Jan; 239():28-37. PubMed ID: 23022919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.